PharmiWeb1h
Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion
Humaneva CEO - Tomasz D?browski WARSAW, Poland, September 27, 2024 (Newswire.com) - Humaneva Inc. has entered into a ...
PharmiWeb4h
Baxter Launches Next Generation of THE VEST for Airway Clearance
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance ...
PharmiWeb1h
Introducing Compassion Center Austin: Pioneering Natural Wellness Solutions Through the Texas Compassionate Use Program (TCUP)
Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the Texas Compassionate Use Program (TCUP). By integrating low-THC cannabis and ...
PharmiWeb20h
Los Angeles Medical Waste Disposal Company Responds to Rise in Needlestick Injuries With In-Depth Guide
The CDC reports that healthcare workers in the U.S. face an estimated 385,000 needlestick and sharps-related injuries every ...
PharmiWeb23h
Pace Life Sciences Expands Capacity and Capability With Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park
Company broadens service offerings and strengthens network by purchasing Catalent’s Center-of-Excellence for Small Molecule ...
PharmiWeb3h
Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval
AGM/EGMShare price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval 27.09.2024 / 11:19 CET/CESTThe issuer is solely responsible for the ...
PharmiWeb5h
Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases
Regulatory Approval/MiscellaneousFormycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases 27.09.2024 / 09:00 ...
PharmiWeb7h
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
LONDON, UNITED KINGDOM / ACCESSWIRE / September 27, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing therapies designed to transform blood disease treatment, ...
PharmiWeb10h
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering
IRVINE, CA / ACCESSWIRE / September 26, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...
PharmiWeb20h
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
Consolidated net revenue was $81.0 million versus $107.4 million in the prior year period. The change primarily reflects the Company's wind down of its Consumer Health Segment as part of the strategic ...
PharmiWeb1d
enVVeno Medical Corporation Announces Proposed Public Offering
IRVINE, CA / ACCESSWIRE / September 26, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...
PharmiWeb20h
Enlighta Inc. Announces Resignation of Director and President
RICHMOND, BC / ACCESSWIRE / September 26, 2024 / Enlighta Inc. (NEX:NLTA.H) announces today that Norman Tsui, a founder and President and long-time director of the company, has resigned from his ...